Clinical Trials on Leukemia, Chronic in Canada
Total 2780 results
-
Versailles HospitalUniversity Hospital, Bordeaux; Maisonneuve-Rosemont HospitalCompletedChronic Myelogenous Leukemia, BCR/ABL PositiveFrance, Canada
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesCanada, United States
-
University Health Network, TorontoNovartis; Mount Sinai Hospital, Canada; Princess Margaret Hospital, CanadaTerminatedChronic Myeloid Leukemia | Chromosome Abnormality | Gastrointestinal Stromal Cell TumorsCanada
-
AbbVieCompleted
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia, Canada
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Fundación Teófilo Hernando, SpainRecruitingChronic Myeloid LeukemiaSpain
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada, Australia, Puerto Rico
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
PETHEMA FoundationCompletedAcute Myeloblastic LeukaemiaSpain
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
Stemline Therapeutics, Inc.CompletedMyelofibrosis | Chronic Myelomonocytic LeukemiaUnited States, Canada
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeSpain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
-
AstraZenecaCompletedChronic Lymphocytic LeukemiaMalaysia, Saudi Arabia, India, Mexico, Brazil, Singapore, Egypt, Taiwan, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Panama, Turkey, United Arab Emirates
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
University of Milano BicoccaCompletedChronic Myeloid LeukemiaCanada, Germany, Israel, Italy, Spain
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
ShireCompleted
-
Hoffmann-La RocheCompleted
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Bristol-Myers SquibbCompletedChronic Myeloid LeukemiaAustralia, Italy, Canada, United States, Germany, Spain, France
-
Epizyme, Inc.Celgene CorporationCompletedAcute Myeloid Leukemia | Leukemia | Acute Lymphocytic Leukemia | Acute LeukemiasUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
University of Milano BicoccaRecruitingChronic Myeloid LeukemiaItaly, Canada, Germany, Spain
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Kartos Therapeutics, Inc.RecruitingChronic Myeloid LeukemiaItaly, Spain, United States, Korea, Republic of, France, Poland, Canada, Russian Federation
-
AstraZenecaActive, not recruiting
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Hoffmann-La RocheCompleted
-
Novartis PharmaceuticalsRecruitingPhiladelphia Chromosome-Positive Chronic Myeloid LeukemiaSingapore, France, Germany, United Arab Emirates, Greece, Italy, Czechia, Hungary, United States, Oman, Malaysia, Korea, Republic of, Turkey, Bulgaria, Canada, Slovakia, United Kingdom, Argentina, Jordan, Romania, South Africa, Sw... and more
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
Astex Pharmaceuticals, Inc.Enrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Spain, Canada, Austria, Slovakia, Bulgaria, Hungary
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States, Canada